Log in

Simple purification ofEscherichia coli-derived recombinant human interleukin-2 expressed with N-terminus fusion of glucagon

  • Published:
Biotechnology and Bioprocess Engineering Aims and scope Submit manuscript

Abstract

Simple procedures have been devised for purifying recombinant human interleukin-2 (hIL-2), which was expressed inEscherichia coli using sequences of glucagon molecules and enterokinase cleavage site as an N-terminus fusion partner. The insoluble aggregates of recombinant fusion protein produced inE. coli cytoplasm were easily dissolved by simple alkaline pH shift (8→12→8). Following enterokinase cleavage, the recombinant hIL-2 was finally purified by one-step reversed-phase HPLC with high purity. The ease and high efficiency of this simple purification process seem to mainly result from the role of used glucagon fusion partner, which could be applied to the production of other therapeutically important proteins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Henney, C. S., K. Kuribayashi, D. E. Kern, and S. Cillis (1981) Interleukin-2 augments natural killer cell activity.Nature 291: 335–338.

    Article  CAS  Google Scholar 

  2. Farrar, W. L., H. M. Johnson, and J. J. Farrar (1981) Regulation of the production of immune interferor and cytotoxic T lymphocytes by interleukin 2.J. Immunol. 126: 1120–1125.

    CAS  Google Scholar 

  3. Lin, S. J., R. L. Roberts, B. J. Ank, O. H. Nguyen, E. K. Thomas, and E. R. Stiehm (1997) Human immunodeficiency virus (HIV) type-1 GP120-specific cell-mediated cytotoxicity (CMC) and natural killer (NK) activity in HIV-infected (HIV+) subjects: enhancement with interleukin-2 (IL-2), IL-12, and IL-15.Clin. Immunol. Immunopathol. 82: 163–173.

    Article  CAS  Google Scholar 

  4. Liang, S. M., B. Allet, K. Rose, M. Hirschi, C. M. Liang, and D. R. Thatcher (1985) Characterization of human interleukin 2 derived fromEscherichia coli.Biochem. J. 229: 429–439.

    CAS  Google Scholar 

  5. Kim, D.-Y., J. Lee, V. Saraswat, and Y.-H. Park, Glucagon-induced self-association of recombinant proteins inEscherichia coli and affinity purification using a fragment of glucagon receptor. Manuscript submitted toBiotechnol. Bioeng.

  6. Weir, M. P. and J. Sparks (1987) Purification and renaturation of recombinant human interleukin-2.Biochem. J. 245: 85–91.

    CAS  Google Scholar 

  7. Kato, K., T. Yamada, K. Kawahara, H. Onda, T. Asano, H. Sugino, and A. Kakinuma (1985) Purification and characterization of recombinant human interleukin-2 produced inEscherichia coli.Biochem. Biophys. Res. Comm. 130: 692–699.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to In-Ho Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Won, HS., Lee, J., Kim, IH. et al. Simple purification ofEscherichia coli-derived recombinant human interleukin-2 expressed with N-terminus fusion of glucagon. Biotechnol. Bioprocess Eng. 5, 13–16 (2000). https://doi.org/10.1007/BF02932346

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02932346

Keywords

Navigation